Company: HROW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021562
Chunk: 107

Company: HARROW, INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 2
Chunk 107
---
 of Shares Purchased (a)  
    Weighted Average
 Grant Date Fair
 Value  
    Total Number of Shares
 Purchased as Part of Publicly Announced Plans
 or Programs (b)  
    Maximum Number of Shares
 That May Yet Be
 Purchased Under the Plans or Programs (b) 
  
    July 1 – July 31 
     -  
     -  
     -  
     - 
  
    August 1 – August 31 
     -  
     -  
          -  
          - 
  
    September 1 – September 30 
     4,262  
    $39.46  
     -  
     - 
  
    Total 
     4,262  
    $39.46  
     -  
     - 

(a)Represents shares withheld to satisfy the payment of tax obligations related to the vesting of restricted stock awards
                                                                                                                                      
(b)We
                                            had no publicly announced repurchase programs for shares of our common stock during the three
                                            months ended September 30, 2025.

Item
3. Defaults Upon Senior Securities

Not
applicable.

Item
4. Mine Safety Disclosures

Not
applicable.

Item
5. Other Information

From
time to time, certain of our executive officers and directors may enter into, amend or terminate written trading arrangements pursuant
to Rule 10b5-1 of the Exchange Act or otherwise. During the nine months ended September 30, 2025, none of our directors or officers adopted
or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation
S-K).

44

Item
6. Exhibits

    Exhibit
    Number

    Description

    2.1
     
    Agreement and Plan of Merger, dated September 24, 2025, by and among Harrow, Inc., Harrow Acquisition Sub, Inc., Melt Pharmaceuticals, Inc., and D. Brad Osborne, as stockholder representative (“Merger Agreement”) (incorporated herein by reference to Exhibit 2.1 to the Current Report on Form 8-K of Harrow, Inc. filed with the Securities and Exchange Commission on October 1, 2025).

    3.1